OBJECTIVE: The aim of this study was to clarify the role of telomerase acti
vity in hepatocellular carcinoma (HCC).
METHODS: Specimens from both HCC and noncancerous liver were obtained from
39 patients with HCC using a 14-gauge biopsy needle immediately after lapar
otomy. Telomerase activity was determined using a telomeric repeat amplific
ation protocol assay. The 3+ of telomerase activity in HCC was defined as a
high telomerase group, and 2+ or less of HCC telomerase activity was defin
ed as a low telomerase group. in noncancerous liver, 2+ or more of telomera
se activity was defined as an increased telomerase group, and 1+ or less of
telomerase activity was defined as a nonincreased telomerase group. The co
rrelation between telomerase activity in HCC or noncancerous Liver and clin
icopathological factors, including prognosis, was investigated.
RESULTS: Telomerase activities in HCCs were 0 in one patient, if in two, 2 in seven, and 3+ in 29 patients. The disease-free survival rate in the hig
h telomerase group was significantly worse than that in the low telomerase
group. The des-gamma-carboxy prothrombin level in a high telomerase group (
median, 330 mAU/ml) was significantly higher than that in the low telomeras
e group (median, 150 mAU/ml). A multivariate analysis revealed that higher
TNM stage, high telomerase activity in HCC, female gender, and high alpha-f
etoprotein value were independent significant factors related to be early r
ecurrence. The incidence of multicentric HCC occurrence in the increased te
lomerase group (53.3%) tended to be higher than that in the nonincreased te
lomerase group (27.3%).
CONCLUSION: A high telomerase activity in HCC correlated with the potential
of HCC to be more malignant, which was expressed as both a high level of d
es-gamma-carboxy prothrombin and an earlier recurrence after hepatectomy th
an that of HCC with a low telomerase activity. (Am J Gastroenterol 2000,95:
748-752. (C) 2000 by Am. Coll. of Gastroenterology).